Overview

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Open-label treatment with MPC-7869 for participants in a previous randomized study.
Phase:
Phase 3
Details
Lead Sponsor:
Myrexis Inc.
Treatments:
Flurbiprofen